269 related articles for article (PubMed ID: 26519843)
1. Seroprevalence of parvovirus B19 antibodies among young pregnant women or planning pregnancy, tested for toxoplasmosis.
Zajkowska A; Garkowski A; Czupryna P; Moniuszko A; Król ME; Szamatowicz J; Pancewicz S
Przegl Epidemiol; 2015; 69(3):479-82, 597-600. PubMed ID: 26519843
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of complications during pregnancy in women with serological features of acute toxoplasmosis or acute parvovirosis].
Marcinek P; Nowakowska D; Szaflik K; Spiewak E; Małafiej E; Wilczyński J
Ginekol Pol; 2008 Mar; 79(3):186-91. PubMed ID: 18592853
[TBL] [Abstract][Full Text] [Related]
3. [NEW APPROACH IN DIAGNOSTIC ALGORITHM OF AN INFECTIOUS AGENTS (PARVOVIRUS B19 AND CHLAMYDIA TRACHOMATIS) INVOLVED IN THE DEVELOPMENT OF PATHOLOGICAL PREGNANCY].
Voleva S; Ivanova S; Marinov B; Genova-Kalou P; Manolov V; Vasilev V
Akush Ginekol (Sofiia); 2016; 55(3):30-9. PubMed ID: 27514136
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of parvovirus B19 antibodies in pregnant women in northern Benin.
De Paschale M; Ceriani C; Cerulli T; Cagnin D; Cavallari S; Zaongo D; Diombo K; Priuli G; Viganò P; Finazzi S; Clerici P
Trop Med Int Health; 2023 Mar; 28(3):226-231. PubMed ID: 36647788
[TBL] [Abstract][Full Text] [Related]
5. Human parvovirus B19 and low hemoglobin levels in pregnant Sudanese women.
Gasim GI; Eltayeb R; Elhassan EM; Haggaz AD; Rayis DA; Adam I
Int J Gynaecol Obstet; 2016 Mar; 132(3):318-20. PubMed ID: 26674318
[TBL] [Abstract][Full Text] [Related]
6. Detection of cytomegalovirus, human parvovirus B19, and herpes simplex virus-1/2 in women with first-trimester spontaneous abortions.
Zhou Y; Bian G; Zhou Q; Gao Z; Liao P; Liu Y; He M
J Med Virol; 2015 Oct; 87(10):1749-53. PubMed ID: 25976377
[TBL] [Abstract][Full Text] [Related]
7. [Seroprevalence and risk factors of Toxoplasma gondii infection among pregnant women in Wuxi region].
Zhou JJ; Tao LL
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2015 Dec; 27(6):604-7. PubMed ID: 27097478
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Placenta PCR and Maternal Serology of Aborted Women for Detection of Toxoplasma gondii in Ardabil, Iran.
Matin S; Shahbazi G; Namin ST; Moradpour R; Feizi F; Piri-Dogahe H
Korean J Parasitol; 2017 Dec; 55(6):607-611. PubMed ID: 29320815
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India.
Jain P; Jain A; Prakash S; Khan DN; Singh DD; Kumar A; Moulik NR; Chandra T
J Med Virol; 2015 Feb; 87(2):303-9. PubMed ID: 25087946
[TBL] [Abstract][Full Text] [Related]
11. The seroprevalence of parvovirus B19 infection in pregnant women in Sudan.
Adam O; Makkawi T; Reber U; Kirberg H; Eis-Hübinger AM
Epidemiol Infect; 2015 Jan; 143(2):242-8. PubMed ID: 24650427
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and genotypic characterization of Human Parvovirus B19 in children with measles- and rubella-like illness in Iran.
Rezaei F; Sarshari B; Ghavami N; Meysami P; Shadab A; Salimi H; Mokhtari-Azad T
J Med Virol; 2016 Jun; 88(6):947-53. PubMed ID: 26538067
[TBL] [Abstract][Full Text] [Related]
13. Serological survey and risk factors associated with
Zakari MM; Isah AY; Offiong R; Yunusa T; Abdullahi IN
Malawi Med J; 2020 Sep; 32(3):160-167. PubMed ID: 33488988
[TBL] [Abstract][Full Text] [Related]
14. Serological detection of human parvovirus B19 infection and associated risk factors among pregnant women in Jigawa State, Nigeria.
Safiyanu MB; Akande AO; Babayo A; Umar J; Abdullahi IN
J Immunoassay Immunochem; 2021 Jul; 42(4):380-392. PubMed ID: 33591885
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of parvovirus B19 IgG and IgM antibodies among pregnant women in Oyo State, Nigeria.
Abiodun I; Opaleye OO; Ojurongbe O; Fagbami AH
J Infect Dev Ctries; 2013 Dec; 7(12):946-50. PubMed ID: 24334941
[TBL] [Abstract][Full Text] [Related]
16. Microsphere-Based IgM and IgG Avidity Assays for Human Parvovirus B19, Human Cytomegalovirus, and Toxoplasma gondii.
Wang Y; Hedman L; Nurmi V; Ziemele I; Perdomo MF; Söderlund-Venermo M; Hedman K
mSphere; 2020 Mar; 5(2):. PubMed ID: 32188754
[TBL] [Abstract][Full Text] [Related]
17. Detection of Toxoplasma gondii B1 Gene and IgM in IgG Seropositive Pregnant Women.
Sardarian K; Maghsood AH; Farimani M; Hajilooi M; Saidijam M; Ghane ZZ; Mahaki H; Zamani A
Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775900
[TBL] [Abstract][Full Text] [Related]
18. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics.
Enders M; Schalasta G; Baisch C; Weidner A; Pukkila L; Kaikkonen L; Lankinen H; Hedman L; Söderlund-Venermo M; Hedman K
J Clin Virol; 2006 Apr; 35(4):400-6. PubMed ID: 16332455
[TBL] [Abstract][Full Text] [Related]
19. The Chemokine CXCL-10 Is a Marker of Infection Stage in Individuals With DNAemia Due to Parvovirus B19.
Weseslindtner L; Aberle JH; Hedman L; Hedman K
J Infect Dis; 2017 Jan; 215(2):214-220. PubMed ID: 27789725
[TBL] [Abstract][Full Text] [Related]
20. Serological and virological analysis of maternal and fetal blood samples in prenatal human parvovirus b19 infection.
Weiffenbach J; Bald R; Gloning KP; Minderer S; Gärtner BC; Weidner A; Hanke M; Enders M
J Infect Dis; 2012 Mar; 205(5):782-8. PubMed ID: 22275404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
